Cor Vasa 2020, 62(6):567-573 | DOI: 10.33678/cor.2020.089
Do patients with heart failure and preserved, mid-range or reduced ejection fraction have different outcomes?
- a Cardiology Clinic, Department of Internal Diseases "Kirkovich", University Hospital Alexandrovska, Sofia, Bulgaria
- b Department of Electrocardiostimulation and Electrocardiophysiology, University Hospital Saint Ekaterina, Sofia, Bulgaria
Introduction: The therapeutic strategies and prognosis in heart failure with reduced ejection fraction (HFrEF) are well established. However, the prognosis of HF patients with preserved EF (HFpEF) and HF with mid-range EF (HFmrEF) remains not well understood. Purpose: To investigate the risk factors, clinical and echocardiographic characteristics and prognosis of Bulgarian patients with HFpEF, HFmrEF, and HFrEF.
Methods: In this observational study 890 patients were included. All of them were admitted to our Cardiology department between the years 2012 and 2014 for decompensated chronic HF.
Results: The patients with HFpEF (609, 68.4%), HFmrEF (145, 16.3%), and HFrEF (136, 15.3%) were followed up for all-cause mortality and rehospitalizations. The adjusted 5.8 years mortality rate was significantly higher in HFrEF (61.8%) and HFmrEF (55.9%) versus HFpEF (34.6%). After the second year of follow-up the HFrEF patients had a non-significantly reduced survival versus HFmrEF ones. Over a period of 1.2 year the HFrEF and HFmrEF patients had significantly higher risk of readmissions due to decompensated HF (33.7%
Keywords: Heart failure, Mid-range ejection fraction, Mortality, Rehospitalizations
Received: June 25, 2020; Revised: September 21, 2020; Accepted: October 9, 2020; Published: December 11, 2020 Show citation
References
- Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-2200.
Go to original source...
Go to PubMed...
- Runev N, Manov E. Diastolic left ventricular function - invasive assessment. Lambert Academic Publishing, 2014.
- Naydenov S, Donova T, Runev N, Manov E. Atrial fibrillation and heart failure: clinical and instrumental analysis. Bulg Cardiol 2012;18(Suppl. 2):16.
- Tasheva R, Grigorov Ml, Runev N, Vitlianova K. Clinical utility of NT-proBNP for assessment of the left ventricular end-diastolic pressure in chronic heart failure patients with preserved ejection fraction. Bulg Cardiol 2015;3:33-38.
- Naydenov S, Runev N, Manov E, et al. Risk Factors, Co-Morbidities and Treatment of In-Hospital Patients with Atrial Fibrillation in Bulgaria. Medicina (Kaunas) 2018;54(3):34.
Go to original source...
Go to PubMed...
- Pancheva R, Runev N, Manov E, et al. A gradient of frequency of rehospitalization of heart failure patients between different types of atrial fibrillation and correlation with left atrial diameter. Eur J Heart Fail 2018;20(Suppl. S1):243.
- Runev N, Manov E, Naydenov S, Donova T. Prevalence of the cardiovascular risk factors in Bulgarian female population. Eur J Prev Cardiol 2015;22(Suppl. 1):S103.
- Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res 2019;124:1598-1617.
Go to original source...
Go to PubMed...
- Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2017;14:591-602.
Go to original source...
Go to PubMed...
- Shah SJ, Kitzman DW, Borlaug BA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation 2016;134:73-90.
Go to original source...
Go to PubMed...
- Pancheva R, Runev N, Manov E, et al. Predictors of mid-term rehospitalization and mortality rates in Bulgarian patients with heart failure and preserved ejection fraction: a single- -center study. Eur J Heart Fail 2018;20(Suppl. S1):573.
- Pancheva R, Runev N, Manov E, et al. Which patients with heart failure and preserved ejection fraction in Bulgaria are more likely to be rehospitalized and have higher mortality rate? Acta Medica Mediterr 2019;35:2575-2582.
- Andersson C, Vasan R. Epidemiology of heart failure with preserved ejection fraction. Heart Fail Clin 2014;10:377-388.
Go to original source...
Go to PubMed...
- Fonarow GC, Stough WG, Abraham WT, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007;50:768-777.
Go to original source...
Go to PubMed...
- Meta-analysis Global Group in Chronic Heart Failure. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012;33:1750-1757.
- Lenzen MJ, Scholte op Reimer WJ, Boersma E, et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004;25:1214-1220.
Go to original source...
Go to PubMed...
- Steinberg BA, Zhao X, Heidenreich PA, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 2012;126:65-75.
Go to original source...
Go to PubMed...
- Pancheva R, Runev N, Manov E, et al. Predictors of mid-term rehospitalization and mortality rates in Bulgarian patients with heart failure and mid-range ejection fraction: a single- -center study. Eur J Heart Fail 2018;20(Suppl. S1):59.
- Pancheva R, Runev N, Manov E, et al. The rehospitalization rates among patients with preserved, mid-range and reduced ejection fraction: databased analysis. Eur J Heart Fail 2018;20(Suppl. S1):241.
- Lauritsen J, Gustafsson F, Abdulla J. Characteristics and long--term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta-analysis. ESC Heart Fail 2018;5:685-694.
Go to original source...
Go to PubMed...
- Lofman I, Szummer K, Dahlstrom U, et al. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. Eur J Heart Fail 2017;19:1606-1614.
Go to original source...
Go to PubMed...
- Coles AH, Tisminetzky M, Yarzebski J, et al. Magnitude of and prognostic factors associated with 1-year mortality after hospital discharge for acute decompensated heart failure based on ejection fraction findings. J Am Heart Assoc 2015;4:e002303.
Go to original source...
Go to PubMed...
- Gomez-Otero I, Ferrero-Gregori A, Varela Roman A, et al. Mid-range ejection fraction does not permit risk stratification among patients hospitalized for heart failure. Rev Esp Cardiol 2017;70:338-346.
Go to original source...
Go to PubMed...
- Pascual-Figal DA, Ferrero-Gregori A, Gomez-Otero I, et al. Mid-range left ventricular ejection fraction: clinical profile and cause of death in ambulatory patients with chronic heart failure. Int J Cardiol 2017;240:265-270.
Go to original source...
Go to PubMed...
- Rickenbacher P, Kaufmann BA, Maeder MT, et al. Heart failure with mid-range ejection fraction: a distinct clinical entity?Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Eur J Heart Fail 2017;19:1586-1596.
Go to original source...
Go to PubMed...
- Koh AS, Tay WT, Teng THK, et al. A comprehensive population-based characterization of heart failure with mid- -range ejection fraction. Eur J Heart Fail 2017;19:1624-1634.
Go to original source...
Go to PubMed...
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 2018;39:3021-3104.
Go to original source...
Go to PubMed...
- Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-2791.
Go to original source...
Go to PubMed...
- Inker LA, Astor BC, Fox CH, et al. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD. Am J Kidney Dis 2014;63:713-735.
Go to original source...
Go to PubMed...
- Crespo-Leiro MG, Anker SD, Maggioni AP, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC--HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail 2016;18:613-625.
Go to original source...
Go to PubMed...
- Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-259.
Go to original source...
Go to PubMed...
- Varadarajan P, Pai RG. Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients. J Card Fail 2003;9:107-112.
Go to original source...
Go to PubMed...
- Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-269.
Go to original source...
Go to PubMed...
- Somaratne JB, Berry C, McMurray JJ, et al. The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature based meta-analysis. Eur J Heart Fail 2009;11:855-862.
Go to original source...
Go to PubMed...
- Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002;137:631-639.
Go to original source...
Go to PubMed...
- O'Meara E, Clayton T, McEntegart MB, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006;113:986-994.
Go to original source...
Go to PubMed...
- Fonarow GC, Stough WG, Abraham WT, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007;50:768-777.
Go to original source...
Go to PubMed...
- Sweitzer NK, Lopatin M, Yancy CW, et al. Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (≥55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (
- Cheng RK, Cox M, Neely ML, et al. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J 2014;168:721-730.
Go to original source...
Go to PubMed...
- Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S. Clinical characteristics and outcomes of heart failure with preserved ejection fraction: Lessons from epidemiological studies. J Cardiol 2010;55:13-22.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.